16
168330.KQ Naturalendo Tech Co Ltd
- Market cap
- KRW 66.0B
- P/E
- -
- P/B
- 2.78x
- ROE
- -1.7%
- Dividend yield
- -
- Fundamental score
- 1.4/5
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 168330.KQ undervalued?
Graham numberThe Graham number of Naturalendo Tech Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Naturalendo Tech Co Ltd fundamental analysis
6 of 21 checks passedROE 0/2
Low return on equity (-1.7%), below 10%.
ROA 1/1
Return on assets (-1.1%) is above the industry median (-10.1%).
Profit Consistency 0/2
Not profitable for at least 3 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share history is shorter than 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 1/1
Last year's EPS growth (17.1%) is above the industry median (4.8%).
Revenue Growth 2/2
Revenue grew 16.8% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (13.9%), 40% or less.
Debt Trend 0/1
Debt to equity history is shorter than 5 years.
Cash Runway 0/2
Cash covers 0.5 years of the current cash burn.
PE vs Market 0/1
PE is negative or not available.
PE vs Industry 0/1
PE is negative or not available.
PBV 0/1
Price to book (2.8x) is above the industry median (2.4x).
Graham Number 0/1
Graham number needs positive earnings and book value.
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Naturalendo Tech Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Naturalendo Tech Co Ltd
Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex fo…
Full company profileNaturalendo Tech Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Naturalendo Tech Co Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 124B | 44.5B | 6.56B | 9.24B | 8.93B | 14.0B | 18.8B | 22.3B | 22.2B | 23.7B |
| Gross Profit | 84.4B | 30.5B | 440M | 3.29B | -3.16B | 1.49B | 5.90B | 9.52B | 9.60B | 10.6B |
| Operating Income | 25.9B | -10.9B | -11.2B | -5.39B | -13.6B | -8.44B | -4.08B | -3.77B | -3.29B | -528M |
| EBITDA | - | - | - | - | - | -8.88B | -3.93B | -2.65B | -2.52B | 565M |
| Net Income | 20.8B | -15.5B | -13.2B | -8.86B | -19.5B | -10.1B | -4.37B | -3.89B | -3.22B | -409M |
| EPS | - | - | - | - | - | -319 | -138 | -123 | -102 | -13 |
| Balance Sheet | ||||||||||
| Total Assets | 88.7B | 69.4B | 85.9B | 85.7B | 61.2B | 39.8B | 37.2B | 33.3B | 35.8B | 37.6B |
| Total Liabilities | 17.1B | 19.0B | 38.6B | 31.0B | 24.7B | 3.23B | 6.26B | 6.47B | 12.6B | 14.7B |
| Shareholders' Equity | 71.6B | 50.5B | 47.3B | 47.6B | 33.1B | 35.5B | 31.1B | 27.2B | 24.0B | 23.8B |
| Cash & Short-term Investments | 15.1B | 6.63B | 16.3B | 6.45B | 7.23B | 1.24B | 632M | 224M | 296M | 268M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 10.4B | -7.35B | -18.3B | -7.52B | -8.15B | -4.54B | -3.41B | -2.14B | -5.66B | -58.5M |
| Capital Expenditure | 35.2B | 2.05B | 596M | 548M | 2.42B | 1.21B | 2.45B | 317M | 190M | 489M |
| Free Cash Flow | - | - | - | - | - | -5.75B | -5.86B | -2.45B | -5.85B | -548M |
| Ratios | ||||||||||
| ROE | 29.0% | -30.7% | -27.9% | -18.6% | -58.9% | -28.4% | -14.1% | -14.3% | -13.4% | -1.7% |
| ROA | 23.4% | -22.3% | -15.3% | -10.3% | -31.9% | -25.3% | -11.7% | -11.7% | -9.0% | -1.1% |
| Net Profit Margin | 16.7% | -34.9% | -201.0% | -95.9% | -218.4% | -72.3% | -23.2% | -17.5% | -14.5% | -1.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Naturalendo Tech Co Ltd dividends
Naturalendo Tech Co Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1.8:1 on Aug 1, 2014.
Who owns Naturalendo Tech Co Ltd
- Insiders 43.71%
- Institutions 0.00%
- Public & others 56.29%
- Shares outstanding 31.6M
- Free float 15.1M
Naturalendo Tech Co Ltd company profile
- Company name
- Naturalendo Tech Co Ltd
- Ticker
- 168330.KQ
- ISIN
- KR7168330009
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 83
- Fiscal year end
- December
- Address
- C's Tower, Sampyeong-dong, Seongnam-si, South Korea
- Phone
- 82 70 4601 3139
- Website
- naturalendo.co.kr
About Naturalendo Tech Co Ltd
Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a ultimate men's prostate and urinary support; and Quercus acuta Thunb. fruit extract for preventing skin aging caused by ultraviolet rays. It also provides daily toner pad, anti-trouble patch, cleansing gel, and mild enzyme cleansing powder under the NEEDLY brand; and bium and guma enzyme powder, haru diet burning, and bium diet clean under the NEEDIN brand. Naturalendo Tech Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.
Naturalendo Tech Co Ltd management
1- Mr. Hee-do KimChief Executive Officer & Internal Director · born 1973